Indian health-tech pioneer develops the world’s first digital vaccine candidate for COVID-19

New Delhi [India] July 31 (ANI/Digpu): In the worldwide race towards time for a COVID-19 vaccine, this may very well be a game-changing scientific breakthrough. Indian serial entrepreneur and investor, Bhargav Sri Prakash, Founder & CEO of well being tech pioneer, FriendsLearn have expanded a longstanding partnership with information scientists and AI researchers on the Heinz College of Information Systems and Public Policy at Carnegie Mellon University (Pittsburgh, USA) to undertake a proposed inhabitants well being human trial with a Digital Vaccine candidate (FYA-003) for COVID-19.
This initiative is led by healthcare informatics and analytics knowledgeable within the area, Prof Rema Padman and her staff, by way of revolutionary extensions of the Digital Vaccine Project.
Digital vaccines have been described as a brand new frontier of illness prevention by way of expertise that permits neuro-behaviour and physiological modulation to guard well being at a person and societal scale. Carnegie Mellon University featured digital vaccines as a prime breakthrough in expertise as a part of their yr in evaluation annual publication, which is particularly noteworthy, on condition that Carnegie Mellon University is the birthplace of Artificial Intelligence.
After almost a decade of basic neuroscience discoveries and translational scientific analysis in using AI and mobile-VR applied sciences, digital vaccines emerge with huge potential to disrupt the world of drugs, by way of a concentrate on precision prevention vs precision drugs.
FriendsLearn already delivers non-invasive, low-risk, and clinically-proven digital vaccine expertise by way of a commercially out there, subscription-driven, game-like, cellular App referred to as FOOYA! for youngsters to obtain on iOS/Android/PCs. The app can also be out there by way of choose companion colleges in India.
Based on revealed outcomes from 4 pilot, cross-sectional medical trials carried out with over 1000 youngsters, researchers discovered that youngsters who use FOOYA! make more healthy meals decisions in the true world.
A latest publication within the journal of worldwide well being promotion by impartial researchers featured FOOYA! as a part of a scientific evaluation – thought of the gold customary in evidence-based drugs – and concluded that the game-like expertise of FOOYA! resulted in higher engagement from youngsters.
Results from a dose-effect randomized managed trial undertaken by researchers at Carnegie Mellon University, Bloomberg School of Public Health at Johns Hopkins University and Hofstra University, confirmed constructive and statistically vital outcomes, which had been offered through the JMIR Connected Health Conference in Boston, USA.
FYA-003, a digital vaccine candidate for Covid-19, is a repurposed variant of the prevailing digital vaccine platform. “We are re-purposing the mechanisms and technology from FOOYA! to help fight the global Covid-19 pandemic,” stated Sri Prakash.
“The technology has been developed and population-scale human trials are being planned soon, after which relevant scientific, ethical and regulatory approvals can be secured. By leveraging the FOOYA! the scientific evidence base, we aim for another drug-free and non-invasive digital vaccine that can save lives, without one having to inject or ingest anything that may have long term undesirable side effects,” added Sri Prakash.
Like FOOYA! FYA-003 will concentrate on neuromodulation and neurocognitive coaching by way of immersive digital actuality to induce neuro-behavior-physiological change by way of the gut-brain axis and the physique’s immune system. Unlike FOOYA! which was focused at youngsters, FYA-003 is envisioned extra broadly for a wider age group.
“FOOYA! has already demonstrated promising evidence for science-based digital vaccine innovation that is targeted towards lowering the risk of lifestyle-related disease among children. We are currently in the process of adapting and scaling the existing platform towards supporting large scale, longitudinal, randomized field trials and conducting ongoing R&D to gather and analyze evidence of a variety of critical outcomes of interest to individuals and society. Global adoption of a digital vaccine for infectious diseases has the potential to help alleviate current health challenges caused by COVID-19, as well as for other infectious diseases in the future,” stated Prof Rema Padman of Carnegie Mellon University.
Accredited college well being companions which might be already utilizing the FOOYA! App-based youngster well being safety platform shall be preferentially eligible to take part on this ongoing analysis collaboration with the Digital Vaccine Project at Carnegie Mellon University, for validation of FYA-003.
This story is offered by Digpu. ANI is not going to be accountable in any means for the content material of this text. (ANI/Digpu)

Disclaimer: The views expressed within the article above are these of the authors’ and don’t essentially symbolize or mirror the views of this publishing home. Unless in any other case famous, the creator is writing in his/her private capability. They usually are not supposed and shouldn’t be thought to symbolize official concepts, attitudes, or insurance policies of any company or establishment.


LEAVE A REPLY

Please enter your comment!
Please enter your name here